Inclusion criteria for pharmacodynamic and clinical trials in chronic idiopathic constipation: pitfalls in using Rome III for functional constipation
نویسندگان
چکیده
منابع مشابه
Hydration status in patients diagnosed of chronic idiopathic constipation by rome III criteria.
Introduction: drunkorexia is a new eating disorder characterized by a reduction in food consumption to offset the excess calories provided by the intensive consumption of alcohol (binge drinking). In particular sweets containing a high caloric density and having a low nutritional contribution are one of the main foods whose consumption is being restricted by the subjects who suffer from this di...
متن کاملDiagnosis of functional constipation: Agreement between Rome III and Rome II criteria and evaluation for the practicality
OBJECTIVE To investigate the agreement between Rome III and Rome II criteria for diagnosing functional constipation (FC) and to evaluate the accuracy of each constipation symptom for FC diagnosis. METHODS Patients with chronic constipation underwent rigorous biochemical and endoscopic/imaging tests to exclude organic and metabolic diseases. The questionnaires including general information, co...
متن کاملConstipation in children: an epidemiological study in Sri Lanka using Rome III criteria.
Constipation is a common paediatric problem, but its prevalence in Asia is unknown. A cross-sectional survey using a previously validated, self-administered questionnaire was conducted in randomly selected children aged 10-16 years, in five randomly selected schools in Sri Lanka. Two schools were in Eastern Province, which has been affected by the separatist war. Constipation was defined using ...
متن کاملLinaclotide (Linzess) for Irritable Bowel syndrome With Constipation and For Chronic Idiopathic Constipation.
Linaclotide (Linzess) for irritable bowel syndrome with constipation and for chronic idiopathic constipation.
متن کاملCore Aspects of Clinical Development and Trials in Chronic Idiopathic Constipation
861Huang SM and Woodcock J. (2009). Transporters in drug development:advancing on theCritical Path. Nat Rev Drug Discov. 2010 Mar;9(3):175-6Irving G., Pénzes J., Ramjattan B., et al (2011). A randomized, placebo-controlled phase 3trial (study SB-767905/013) of alvimopan for opioid-induced bowel dysfunction inpatients with non-cancer pain. J Pain. 12:175-84Jansen J.P., Lo...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Therapeutic Advances in Gastroenterology
سال: 2011
ISSN: 1756-2848,1756-2848
DOI: 10.1177/1756283x11401773